News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,995 Results
Type
Article (221)
Company Profile (1)
Press Release (1772)
Section
Business (775)
Career Advice (1)
Deals (122)
Drug Delivery (8)
Drug Development (104)
FDA (18)
Job Trends (27)
News (914)
Policy (99)
Tag
Academia (3)
Alliances (226)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (19)
Approvals (19)
ASCO (1)
Autoimmune disease (11)
Best Places to Work (12)
BIO (1)
BIOSECURE Act (18)
Biotechnology (1)
Cancer (14)
Cardiovascular disease (1)
Career advice (1)
CAR-T (3)
Cell therapy (11)
Clinical research (93)
Collaboration (20)
COVID-19 (8)
C-suite (4)
Data (15)
Diagnostics (16)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (194)
Editorial (2)
Events (173)
Executive appointments (6)
FDA (22)
Funding (5)
Gene therapy (1)
GLP-1 (8)
Government (27)
Healthcare (28)
Immunology and inflammation (3)
Immuno-oncology (1)
Infectious disease (8)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (63)
IRA (1)
Job creations (13)
Job search strategy (1)
JPM (1)
Layoffs (3)
Legal (9)
Lung cancer (2)
Manufacturing (46)
MASH (1)
Medical device (18)
Medtech (18)
Mergers & acquisitions (64)
Metabolic disorders (5)
mRNA (1)
Multiple sclerosis (5)
NASH (1)
Neuroscience (7)
NextGen: Class of 2026 (18)
Non-profit (2)
Obesity (3)
Opinion (5)
Pain (1)
People (168)
Phase 1 (58)
Phase 2 (37)
Phase 3 (15)
Pipeline (48)
Policy (23)
Preclinical (9)
Radiopharmaceuticals (1)
Real estate (64)
Regulatory (79)
Reports (1)
Research institute (1)
Series A (1)
Series B (1)
Startups (40)
Supply chain (4)
Tariffs (1)
The Weekly (4)
Vaccines (4)
Venture capital (1)
Weight loss (2)
Date
Today (1)
Last 7 days (4)
Last 30 days (9)
Last 365 days (113)
2026 (69)
2025 (93)
2024 (127)
2023 (113)
2022 (218)
2021 (205)
2020 (159)
2019 (116)
2018 (132)
2017 (117)
2016 (97)
2015 (117)
2014 (76)
2013 (60)
2012 (43)
2011 (38)
2010 (48)
Location
Africa (2)
Asia (986)
Australia (13)
California (26)
Canada (2)
China (85)
Delaware (2)
Europe (149)
Florida (5)
Illinois (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (29)
New Jersey (31)
New York (1)
North Carolina (1)
Northern California (17)
Ohio (2)
Pennsylvania (4)
South America (2)
Southern California (5)
Texas (1)
United States (104)
Utah (1)
Washington D.C. (3)
1,995 Results for "wuxi nextcode".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
July 8, 2026
·
4 min read
Press Releases
WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
June 30, 2026
·
4 min read
Press Releases
WuXi Biologics’ MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy
July 9, 2026
·
4 min read
Press Releases
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
June 5, 2026
·
4 min read
Press Releases
WuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
June 18, 2026
·
4 min read
Press Releases
WuXi Vaccines’ Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing
May 26, 2026
·
2 min read
Press Releases
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026
April 27, 2026
·
16 min read
Press Releases
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
May 13, 2026
·
3 min read
Press Releases
WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
April 29, 2026
·
8 min read
Press Releases
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
May 27, 2026
·
4 min read
1 of 200
Next
